Clinical Trials Browser

Burkitt Lymphoma, Hodgkin Disease, Immunoblastic Lymphadenopathy, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Mycosis Fungoides, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, Large-Cell, Anaplastic, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Extranodal NK-T-Cell

Clinical Trials

PEG-ASP+Gemox Regimen and Thalidomide for NK/T Lymphoma

Efficacy and Safety Study of P-Gemox vs.EPOCH as First-line Chemotherapy to Treat NK/T-cell Lymphoma With Early Stage

P-Gemox Regimen as First-line Chemotherapy in NK/T Lymphoma Patiens

Combine GELOX With Concurrent Radiation Therapy for Patients With Stage IE/IIE ENKTL

Avastin+ GemAOD As First-Line Treatment in NK/T Cell Lymphoma

Pemetrexed and Oxaliplatin in Treating Patients With Metastatic Solid Tumors or Lymphoma